Research Ethics Oversight for Multi-jurisdictional Clinical Trials in Canada: A Historical Perspective to Inform Future Direction
DOI:
https://doi.org/10.7202/1112276arKeywords:
research ethics, pan-Canadian, harmonization, clinical trialsLanguage(s):
EnglishAbstract
As a condition of funding from the Canadian Tri-Agencies, researchers and institutions are expected to adhere to the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS) and research projects must obtain approval from a Research Ethics Board (REB). Yet there are a limited number of frameworks and standards to guide the conduct and decisions of REBs in Canada and these are most often voluntary. Delays and increased costs resulting from the lack of a common or coordinated approach to REB review for multi-jurisdictional clinical trials is a long-standing issue in the Canadian research environment. Formal reviews and recommendations as early as 2006 call for accreditation or qualification for REBs, use of common forms and templates, and federal leadership to harmonize processes.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Brenda Lucas, Jaime Flamenbaum, Holly Longstaff, Srinivas Murthy, Brittney Schichter
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Canadian Journal of Bioethics applies the Creative Commons Attribution 4.0 International License to all its publications. Authors therefore retain copyright of their publication, e.g., they can reuse their publication, link to it on their home page or institutional website, deposit a PDF in a public repository. However, the authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy their publication, so long as the original authors and source are cited.